MECHANISM OF ACTION

TYVASO IS A DIRECT-TO-LUNG, INHALED PROSTACYCLIN

TYVASO promotes direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation.1

TREAT AT THE SITE OF DISEASE

  • TYVASO is delivered directly to the lungs, which are highly vascularized, providing an enormous surface area for drug absorption and an attractive target for drug delivery1-3
  • TYVASO is inhaled directly to distal airspaces that are in close proximity to pulmonary arterioles affected by PAH4

Direct-to-lung delivery results in higher concentrations in the pulmonary arterial vasculature, which may selectively enhance blood flow for better ventilation and perfusion matching with less off-target exposure.2

TYVASO’s direct-to-lung delivery results in higher concentrations of the drug in the pulmonary arterial vasculature.TYVASO’s direct-to-lung delivery results in higher concentrations of the drug in the pulmonary arterial vasculature.

TYVASO INHALATION SYSTEM

Find additional resources and information on how TYVASO is used for direct-to-lung delivery of inhaled prostacyclin.

LEARN MORE